The European Union's Sixth Anti-Money Laundering Directive (6AMLD) came into effect in all EU member states in December 2020, and it must be enforced by all regulated financial institutions by 3rd June 2021. Companies operating in Europe—and multinationals based...
Since the mid-1990s, regulatory expectations on the due diligence carried out in the pharmaceutical sector have become much more complicated. Drugs firms are subject to regulations laid out in the US Foreign Corrupt Practices Act and by the US Food and Drug Administration...
The novel coronavirus, or COVID-19, has already changed society. As governments worldwide struggle to adapt to the new reality, they are introducing measures aimed at preventing the further spread of the virus and increasing the resilience of their public healthcare...